Roche inks $1.5B Poseida buyout to land off-the-shelf CAR-Ts
Roche has struck a $1.5 billion deal to buy Poseida Therapeutics. The takeover will establish off-the-shelf cell therapies, which…
Tariffs make M&A decisions ‘more difficult,’ says Roche CEO
Big Pharma’s M&A plans will likely take a hit if the U.S. government under the Trump administration lives…